OPRX Insider Trading
Insider Ownership Percentage: 6.10%
Insider Buying (Last 12 Months): $2,542,900.80
Insider Selling (Last 12 Months): $0.00
OptimizeRx Share Price & Price History
Current Price: $8.64
Price Change: ▼ Price Decrease of -0.1 (-1.14%)
As of 03/28/2025 05:00 PM ET
OptimizeRx Insider Trading History
OptimizeRx Institutional Trading History
Data available starting January 2016
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
Read More on OptimizeRx
Volume
200,589 shs
Average Volume
260,234 shs
Market Capitalization
$159.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.31
Who are the company insiders with the largest holdings of OptimizeRx?
Who are the major institutional investors of OptimizeRx?
OptimizeRx's top institutional investors include:
- Whetstone Capital Advisors LLC — 7.33%
- Royce & Associates LP — 5.81%
- Blair William & Co. IL — 3.26%
- Kennedy Capital Management LLC — 3.22%
- Rice Hall James & Associates LLC — 3.14%
- Dimensional Fund Advisors LP — 2.41%
Learn More about top institutional investors of OptimizeRx stock.
Which institutional investors are selling OptimizeRx stock?
Within the last quarter, OPRX stock was sold by these institutional investors:
- AWM Investment Company Inc.
- G2 Investment Partners Management LLC
- Blair William & Co. IL
- Rice Hall James & Associates LLC
- Sherbrooke Park Advisers LLC
- Boothbay Fund Management LLC
- Janney Montgomery Scott LLC
- Bullseye Asset Management LLC
Which institutional investors are buying OptimizeRx stock?
In the last quarter, OPRX stock was bought by institutional investors including:
- Whetstone Capital Advisors LLC
- Royce & Associates LP
- Tang Capital Management LLC
- Kennedy Capital Management LLC
- Walleye Capital LLC
- Marshall Wace LLP
- Manatuck Hill Partners LLC
- JPMorgan Chase & Co.
During the last year, these company insiders have bought OptimizeRx stock:
- William J Febbo (CEO)
- James Paul Lang (Director)
Learn More investors buying OptimizeRx stock.